Cargando…
13.3 EFFECTS OF CANNABINOIDS ON A HUMAN OLIGODENDROCYTE CULTURE: IMPLICATIONS FOR SCHIZOPHRENIA
BACKGROUND: Preclinical studies have suggested the involvement of the endocannabinoid system in schizophrenia pathobiology. The effects of cannabinoid drugs in several animal models for schizophrenia have been used to understand the pathobiology of the disease, and to investigate potential treatment...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888317/ http://dx.doi.org/10.1093/schbul/sby014.051 |